secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rafael Holdings, Inc. (RFL)
CIK:        0001713863
Form:       8-K
Filed at:   2022-11-15T23:59:59+00:00
Accession:  0001213900-22-072790
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.05, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rafael Holdings curtails early-stage R&D, shifts to clinical-stage deals; $0.5M severance
--------------------------------------------------------------------------------

- Curtailed early-stage development, including pre-clinical research at Barer Institute, to reduce spending.
- Expects severance charges of approximately $0.5 million.
- As of July 31, 2022, held $63.2M in cash, cash equivalents, and marketable securities.
- Received $33M net proceeds from real estate sale on August 23, 2022.
- Will focus on acquiring, in-licensing, or investing in clinical-stage assets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1713863/000121390022072790/0001213900-22-072790-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1713863/000121390022072790/ea168718-8k_rafaelhold.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-072790

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer